Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in Genotype 1 Chronic HCV with Insulin Resistance
NCT00370617Phase 4Unknown
- Sponsor
- University of Turin
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of metformin in hepatitis C (HCV), sponsored by University of Turin. Primary endpoint: Sustained Virological Response. Status: unknown.
02
Drugs
metformin
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00370617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00370617.